Bajaj Finserv Healthcare Fund Direct Growth
3Y Annualised
N/A
1.60% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
0.43%
1.60% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
NA
6 years 10 months
9 years 7 months
Fund info
Fund size
₹283.11 Cr
Min. SIP amount
₹1000
Min. Lumpsum amount
₹500
Exit load
0%
if units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. if units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable.
Risk Profile
Very High Risk
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
HDFC Pharma and Healthcare Fund Direct Growth
2nd
HDFC Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
3rd
HDFC Pharma and Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
4th
HDFC Pharma and Healthcare Fund Regular Reinvestment Inc Dist cum Cap Wdrl
5th
HDFC Pharma and Healthcare Fund Regular Payout Inc Dist cum Cap Wdrl
64th
Bajaj Finserv Healthcare Fund Direct Growth
Fund Managers
About Bajaj Finserv Healthcare Fund Direct Growth
Bajaj Finserv Healthcare Fund Direct Growth is a Equity mutual fund scheme from Bajaj Finserv Asset Management Limited. This fund has been in existence for 0 years, having been launched on 2024-12-27. Bajaj Finserv Healthcare Fund Direct Growth has ₹283.11 Cr worth of assets under management (AUM) as of Wed Mar 19 2025. The latest Net Asset Value (NAV) of Bajaj Finserv Healthcare Fund Direct Growth as of Tue Mar 18 2025 is ₹8.962. The fund has an expense ratio of 0.61%, which is medium comparable to most other Equity funds.
Bajaj Finserv Healthcare Fund Direct Growth returns for the last 1 year are NA%. Since launch, it has delivered -10.38% average annual returns.
The Bajaj Finserv Healthcare Fund Direct Growth has the majority of its money invested in Healthcare, null sectors.
Top 5 Holdings of Bajaj Finserv Healthcare Fund Direct Growth.
- Divi's Laboratories Ltd: 9.15%
- Sun Pharmaceuticals Industries Ltd: 8.42%
- Cipla Ltd: 8.29%
- Dr Reddy's Laboratories Ltd: 8.27%
- Apollo Hospitals Enterprise Ltd: 5.00%
AMC Information
Name | Bajaj Finserv Asset Management Limited |
---|---|
Founding Date | 2024-12-27 |
Phone | +91 2071576064 |
Website | www.bajajamc.com |
Address | India |
Tax Implications of Bajaj Finserv Healthcare Fund Direct Growth
Short Term Gains | 20% + applicable Surcharge + 4% Cess |
---|---|
Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from Bajaj Finserv Asset Management Limited

Money MarketLiquid
3Y CAGR
0%
expense ratio
0.11%
fund size
₹4635.44 Cr

Money MarketLiquid
3Y CAGR
0%
expense ratio
0.28%
fund size
₹4635.44 Cr

Money MarketOvernight
3Y CAGR
0%
expense ratio
0.12%
fund size
₹445.56 Cr

Money MarketOvernight
3Y CAGR
0%
expense ratio
0.07%
fund size
₹445.56 Cr

Fixed IncomeMoney Market
3Y CAGR
0%
expense ratio
0.76%
fund size
₹3138.96 Cr
FAQs
What is the current NAV of Bajaj Finserv Healthcare Fund Direct Growth?

What are the average returns of Bajaj Finserv Healthcare Fund Direct Growth?

How do I invest in Bajaj Finserv Healthcare Fund Direct Growth?

What is the expense ratio of Bajaj Finserv Healthcare Fund Direct Growth?

What are net assets under management (AUM) of Bajaj Finserv Healthcare Fund Direct Growth?

What is the PE and PB ratio of Bajaj Finserv Healthcare Fund Direct Growth?

What are the top 5 holdings of Bajaj Finserv Healthcare Fund Direct Growth?

What are the top 3 sectors that Bajaj Finserv Healthcare Fund Direct Growth has invested in?

Who is the manager of Bajaj Finserv Healthcare Fund Direct Growth?

What is the exit load of Bajaj Finserv Healthcare Fund Direct Growth?

How to Redeem Bajaj Finserv Healthcare Fund Direct Growth?

Can I invest in SIP and a Lump Sum of Bajaj Finserv Healthcare Fund Direct Growth?
